Liz Selby, Country Lead for Sanofi Australia and New Zealand, said, "Despite progress in relapsing remitting MS treatments, there remains a significant burden on people with nrSPMS who have limited treatment options to manage their disease progression." …
Sanofi therapy wins Australian registration for non-relapsing secondary progressive MS
May 20, 2026 Latest NewsBioPharma
Latest Video
New Stories
-
New report highlights the potential health-system benefits of pharmacist prescribing
June 9, 2026 - - Latest News -
It was an unintentionally revealing discussion about the history and reality of agreements
June 9, 2026 - - Latest News -
R&D tax shake up risks sending Australia’s biotech talent and jobs overseas
June 9, 2026 - - Latest News -
Rare Cancers Australia co-founder Kate Vines recognised in King's Birthday Honours
June 8, 2026 - - Latest News -
Omico is evolving tumour genomics into hard evidence for precision oncology
June 8, 2026 - - Latest News -
The 'Dispatched' Podcast - Special episode
June 5, 2026 - - Podcast -
Opthea returns to ASX and works to restart eye therapy candidate
June 5, 2026 - - Latest News